CLINICAL_TRIALS
withdrawal
· 2019-02-15
Clinical Trial Update: Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. [Phase 1]
Summary
A Phase 1 trial evaluating vitamin C and liraglutide for hypoglycemia-related oxidative stress, inflammation, and endothelial dysfunction in Type 1 diabetes was…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anna Cruceta | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: WITHDRAWN